Publication:
Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study

Simple item page
dc.contributor.authorJimenez-Jorge, Silvia
dc.contributor.authorPozo Sanchez, Francisco
dc.contributor.authorMateo-Ontañon, Salvador de
dc.contributor.authorDelgado-Sanz, Concepcion
dc.contributor.authorCasas Flecha, Inmaculada
dc.contributor.authorGarcia-Cenoz, Manuel
dc.contributor.authorCastilla Catalán, Jesús
dc.contributor.authorSancho, R
dc.contributor.authorEtxebarriarteun-Aranzabal, L
dc.contributor.authorQuinones, C
dc.contributor.authorMartinez, E
dc.contributor.authorVega, T
dc.contributor.authorGarcia, A
dc.contributor.authorGimenez, J
dc.contributor.authorVanrell, Juana María
dc.contributor.authorCastrillejo, D
dc.contributor.authorLarrauri, Amparo
dc.contributor.funderWorld Health Organization (WHO/OMS)
dc.contributor.funderInstituto de Salud Carlos III
dc.date.accessioned2020-02-03T08:58:39Z
dc.date.available2020-02-03T08:58:39Z
dc.date.issued2014-03-06
dc.description.abstractAdjusted early estimates of the 2013/14 influenza vaccine effectiveness (VE) in Spain for all age groups was 35% (95% CI: -9 to 62), 33% (95% CI: -33 to 67) and 28% (95% CI: -33 to 61) against any influenza virus type, A(H1N1)pdm09 and A(H3N2) viruses, respectively. For the population targeted for vaccination, the adjusted VE was 44% (95% CI: -11 to 72), 36% (95% CI: -64 to 75) and 42% (95% CI: -29 to 74), respectively. These preliminary results in Spain suggest a suboptimal protective effect of the vaccine against circulating influenza viruses.es_ES
dc.description.peerreviewedSíes_ES
dc.description.sponsorshipThis work was supported from the Influenza A(H1N1)pdm09 Programme of the Carlos III Institute of Health (GR09/0017 and PS12/00087). The GR09/0017 received additional funding from the World Health Organization Regional Office for Europe (WHO/Europe)/United States CDC (Centers for Disease Control and Prevention) and Epiconcept.es_ES
dc.format.number9es_ES
dc.format.volume19es_ES
dc.identifier.citationEuro Surveill. 2014 Mar 6;19(9). pii: 20727.es_ES
dc.identifier.doi10.2807/1560-7917.es2014.19.9.20727es_ES
dc.identifier.e-issn1560-7917es_ES
dc.identifier.journalEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletines_ES
dc.identifier.pubmedID24626206es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/9005
dc.language.isoenges_ES
dc.publisherEuropean Centre for Disease Prevention and Control (ECDC)
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PS12/00087es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/GR09/0017es_ES
dc.relation.publisherversionhttps://doi.org/10.2807/1560-7917.es2014.19.9.20727es_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshAdolescentes_ES
dc.subject.meshAdultes_ES
dc.subject.meshAgedes_ES
dc.titleInfluenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA studyes_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicatione5c2a093-57c0-47ce-950f-110bc24fe8f1
relation.isAuthorOfPublication5611ffc3-de88-4908-b20a-9a15a58c060a
relation.isAuthorOfPublicationa214b27d-fdfe-4c57-b57b-0df210b9bd10
relation.isAuthorOfPublicatione89a616b-8c7b-43b9-b3df-2a44c45e0765
relation.isAuthorOfPublicatione2df6e55-f1d3-423b-a72f-fd9a69cf5915
relation.isAuthorOfPublication1cd9dae4-d8db-4946-ace0-94c29d1f775a
relation.isAuthorOfPublicatione77e1f2d-b4e2-4ba5-a853-c2795850dcae
relation.isAuthorOfPublication.latestForDiscoverye5c2a093-57c0-47ce-950f-110bc24fe8f1
relation.isFunderOfPublication0459bf85-31ab-4ddf-8987-a26c724348ad
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublication.latestForDiscovery0459bf85-31ab-4ddf-8987-a26c724348ad
relation.isPublisherOfPublication844b1441-479c-4219-87e5-efc493160a02
relation.isPublisherOfPublication.latestForDiscovery844b1441-479c-4219-87e5-efc493160a02

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
InfluenzaVaccineEffectivenessIn_2014.pdf
Size:
362.05 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Centro Nacional de Epidemiología (CNE)
Centro Nacional de Microbiología (CNM)